Sponsor: Grayken Center for Addiction TTA, a program of Boston Medical Center
Description: This training will provide recommendations for managing substance use disorders throughout the peripartum period, including pregnancy, birth, and post-partum.
This training satisfies 0.75 hours of the required 8 hours of training for DEA-registered practitioners.
Intended audience: Medical professionals with prescriptive authority, nurses and support staff who support them looking to increase provision of care for patients with substance use disorder.
Following this training, participants will have the knowledge necessary to:
- Recognize the major benefits and limitations of methadone and buprenorphine treatment during the peripartum period.
- Identify 3 strategies to mitigate and manage neonatal opioid withdrawal syndrome (NOWS) among infants prenatally exposed to buprenorphine.
- Recall the importance of managing polysubstance use (e.g., alcohol, tobacco, stimulants) during pregnancy.
For more information and to register click here:
This is an open ended event
- no costs